Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45results about How to "Avoid premature release" patented technology

Localized drug delivery using drug-loaded nanocapsules

InactiveUS20050129727A1Prevents premature releaseLimit systemic effectPowder deliveryElectrotherapyDrugDrug delivery
Nanocapsules are disclosed which comprise (a) a drug-containing core and (b) a polyelectrolyte multilayer encapsulating the drug-containing core. The nanocapsules include particles whose largest dimension typically ranges between 50 nm to 10000 nm. In some embodiments, the nanocapsules contain a single drug. In others, the nanocapsules contain multiple drugs, either within the same nanocapsules or within separate populations of nanocapsules. In some embodiments, the nanocapsules comprise surfaces that are functionalized, for example, with ligands that allow for attachment to bodily tissue. In some embodiments of the present invention, the nanocapsules are rendered magnetic or are rendered susceptible to magnetic fields. Also disclosed is a drug delivery method that comprises the steps of (a) providing nanocapsules such as those above; and (b) placing the nanocapsules at a desired location within the body of a subject using an implantable or insertable medical device.
Owner:BOSTON SCI SCIMED INC

Polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation containing same, and preparing methods and application of polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation

The invention relates to a polypeptide-protein-drug-carried solid particulate matter and a double-enteric solid preparation containing the same, and preparing methods and application of the polypeptide-protein-drug-carried solid particulate matter and the double-enteric solid preparation. The solid particulate matter contains polypeptide protein drugs, absorption enhancers and protease inhibitors.The prepared double-enteric solid preparation can resist degradation of gastric acid and gastric intestinal enzymes to the polypeptide protein drugs during oral administration and meanwhile has the colon-specific effect, and absorption of polypeptide proteins in an intestinal tract can be effectively promoted.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI

Enhanced transdermal delivery of active agents

Improved formulations that combine chemical permeation enhancers with additional agents so that the formulations simultaneously penetrate both lipid and cellular matrices provide effective transdermal delivery of active agents.
Owner:AMPERSAND BIOPHARM LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products